Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Na Wei

Showing results (821-830 of 826) with videos related to

Pageof 83
Sort By:
You have reached the last page of results.This site can display upto 826 results.
Journal of Medicinal Chemistry|December 5, 2025
Discovery of Atirmociclib (PF-07220060): A Potent and Selective CDK4 InhibitorGary M Gallego, Cynthia Palmer, Suvi Orr, et al.
Asia Pacific Journal of Clinical Nutrition|October 1, 2015
Emerging malnutrition during hospitalisation independently predicts poor 3-month outcomes after acute stroke: data from a Chinese cohortJing Zhang, Xingquan Zhao, Anxin Wang, et al.
Infectious Diseases of Poverty|July 7, 2025
Trypanosoma dionisii in China: ecology and tentative epidemiologyQin Liu, Mu-Xin Chen, Yu-Chun Cai, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 25, 2023
Identification of small-molecule protein-protein interaction inhibitors for NKG2DAaron A Thompson, Michael B Harbut, Pei-Pei Kung, et al.
Cancer Cell|March 11, 2025
CDK4 selective inhibition improves preclinical anti-tumor efficacy and safetyCynthia L Palmer, Britton Boras, Bernadette Pascual, et al.
Annals of Neurology|June 24, 2025
Clinical and Genetic Findings in a Chinese Cohort of Dentatorubral-Pallidoluysian Atrophy PatientsRu-Ying Yuan, Ya-Fang Chen, Wei Lin, et al.
Pageof 83

Showing results (821-830 of 826) with videos related to

Sort By:
Pageof 83
You have reached the last page of results.This site can display upto 826 results.
Journal of Medicinal Chemistry|December 5, 2025
Discovery of Atirmociclib (PF-07220060): A Potent and Selective CDK4 InhibitorGary M Gallego, Cynthia Palmer, Suvi Orr, et al.
Asia Pacific Journal of Clinical Nutrition|October 1, 2015
Emerging malnutrition during hospitalisation independently predicts poor 3-month outcomes after acute stroke: data from a Chinese cohortJing Zhang, Xingquan Zhao, Anxin Wang, et al.
Infectious Diseases of Poverty|July 7, 2025
Trypanosoma dionisii in China: ecology and tentative epidemiologyQin Liu, Mu-Xin Chen, Yu-Chun Cai, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 25, 2023
Identification of small-molecule protein-protein interaction inhibitors for NKG2DAaron A Thompson, Michael B Harbut, Pei-Pei Kung, et al.
Cancer Cell|March 11, 2025
CDK4 selective inhibition improves preclinical anti-tumor efficacy and safetyCynthia L Palmer, Britton Boras, Bernadette Pascual, et al.
Annals of Neurology|June 24, 2025
Clinical and Genetic Findings in a Chinese Cohort of Dentatorubral-Pallidoluysian Atrophy PatientsRu-Ying Yuan, Ya-Fang Chen, Wei Lin, et al.
Pageof 83